WallStreetZenWallStreetZen

NASDAQ: TBIO
Telesis Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TBIO

Based on 1 analyst offering 12 month price targets for Telesis Bio Inc.
Min Forecast
$5.00+142.72%
Avg Forecast
$5.00+142.72%
Max Forecast
$5.00+142.72%

Should I buy or sell TBIO stock?

Based on 1 analyst offering ratings for Telesis Bio Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TBIO stock forecasts and price targets.

TBIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
KeyBanc
Top 9%
92
Strong BuyMaintains$5.00+142.72%2022-11-09

1 of 1

Forecast return on equity

Is TBIO forecast to generate an efficient return?
Company
N/A
Industry
0.03%
Market
13.26%

Forecast return on assets

Is TBIO forecast to generate an efficient return on assets?
Company
N/A
Industry
0.02%

TBIO earnings per share forecast

What is TBIO's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.27
Avg 2 year Forecast
-$0.30

TBIO revenue forecast

What is TBIO's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$44.8M+112.89%
Avg 2 year Forecast
$116.6M+454.08%
Avg 3 year Forecast
$115.0M+446.47%
TBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TBIO revenue growth forecast

How is TBIO forecast to perform vs Medical Devices companies and vs the US market?
Company
82.9%
Industry
6.66%
Market
9.2%
TBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TBIO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TBIO$2.06$5.00+142.72%Strong Buy
NVNO$6.29$23.00+265.66%Strong Buy
BSGM$1.17$4.00+241.88%Strong Buy
RPID$1.32N/AN/AHold
ISO$1.40$1.60+14.29%Hold
View Top Medical Device Stocks

Telesis Bio Stock Forecast FAQ

Is Telesis Bio Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TBIO) stock is to Strong Buy TBIO stock.

Out of 1 analyst, 1 (100%) are recommending TBIO as a Strong Buy, 0 (0%) are recommending TBIO as a Buy, 0 (0%) are recommending TBIO as a Hold, 0 (0%) are recommending TBIO as a Sell, and 0 (0%) are recommending TBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Telesis Bio stock.

What is TBIO's earnings growth forecast for 2023-2024?

(NASDAQ: TBIO) Telesis Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 29.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.89%.

Telesis Bio's earnings in 2023 is -$52,830,000.On average, 2 Wall Street analysts forecast TBIO's earnings for 2023 to be -$37,492,631, with the lowest TBIO earnings forecast at -$38,378,284, and the highest TBIO earnings forecast at -$36,606,979.

In 2024, TBIO is forecast to generate -$8,856,527 in earnings, with the lowest earnings forecast at -$8,856,527 and the highest earnings forecast at -$8,856,527.

What is TBIO's revenue growth forecast for 2023-2025?

(NASDAQ: TBIO) Telesis Bio's forecast annual revenue growth rate of 82.9% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.66%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Telesis Bio's revenue in 2023 is $21,044,000.On average, 3 Wall Street analysts forecast TBIO's revenue for 2023 to be $1,322,574,714, with the lowest TBIO revenue forecast at $1,018,500,617, and the highest TBIO revenue forecast at $1,579,414,000. On average, 1 Wall Street analysts forecast TBIO's revenue for 2024 to be $3,442,236,866, with the lowest TBIO revenue forecast at $3,442,236,866, and the highest TBIO revenue forecast at $3,442,236,866.

In 2025, TBIO is forecast to generate $3,395,002,055 in revenue, with the lowest revenue forecast at $3,395,002,055 and the highest revenue forecast at $3,395,002,055.

What is TBIO's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: TBIO) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 0.02%.

What is TBIO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TBIO price target, the average TBIO price target is $5.00, with the highest TBIO stock price forecast at $5.00 and the lowest TBIO stock price forecast at $5.00.

The Wall Street analyst predicted that Telesis Bio's share price could reach $5.00 by Nov 9, 2023. The average Telesis Bio stock price prediction forecasts a potential upside of 142.72% from the current TBIO share price of $2.06.

What is TBIO's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: TBIO) Telesis Bio's current Earnings Per Share (EPS) is -$1.68. On average, analysts forecast that TBIO's EPS will be -$1.27 for 2023, with the lowest EPS forecast at -$1.30, and the highest EPS forecast at -$1.24. In 2024, TBIO's EPS is forecast to hit -$0.30 (min: -$0.30, max: -$0.30).

What is TBIO's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: TBIO) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.